CIK: 0001263508 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value ($000): $23,065,323 (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seagen Inc. | 47,270,759 | $6,564,018 | 28.5% | $195.69 | — | COM | 81181C104 |
| ONC | BeiGene, Ltd. | 11,668,897 | $4,061,710 | 17.6% | $136.93 | — | SPONSORED ADR | 07725L102 |
| INCY | Incyte Corporation | 32,001,387 | $2,600,753 | 11.3% | $73.07 | +16.8% | COM | 45337C102 |
| KOD | Kodiak Sciences Inc. | 13,879,952 | $1,573,848 | 6.8% | $28.18 | +384.6% | COM | 50015M109 |
| ACAD | ACADIA Pharmaceuticals Inc. | 41,910,704 | $1,081,296 | 4.7% | $18.86 | +133.5% | COM | 004225108 |
| — | Alexion Pharmaceuticals, Inc. | 3,993,312 | $610,617 | 2.6% | $162.46 | — | COM | 015351109 |
| — | Invitae Corporation | 15,749,182 | $601,776 | 2.6% | $25.40 | — | COM | 46185L103 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $573,068 | 2.5% | $81.02 | +0.8% | COM | 09061G101 |
| ASND | Ascendis Pharma A/S | 3,540,270 | $456,270 | 2.0% | $48.88 | — | SPONSORED ADR | 04351P101 |
| PRLD | Prelude Therapeutics Incorporated | 10,123,824 | $438,665 | 1.9% | $28.24 | +134.9% | COM | 74065P101 |
| ABCL | AbCellera Biologics Inc. | 10,450,180 | $354,888 | 1.5% | $45.73 | -12.9% | COM | 00288U106 |
| ARGX | argenx SE | 1,119,557 | $308,315 | 1.3% | $79.01 | — | SPONSORED ADR | 04016X101 |
| — | IGM Biosciences, Inc. | 3,156,102 | $242,041 | 1.0% | $17.75 | — | COM | 449585108 |
| — | Mirati Therapeutics, Inc. | 1,409,784 | $241,496 | 1.0% | $22.85 | — | COM | 60468T105 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,499,213 | $175,363 | 0.8% | $104.81 | +11.2% | COM | 558868105 |
| — | Amarin Corporation plc | 26,453,422 | $164,276 | 0.7% | $8.93 | — | SPONSORED ADR | 023111206 |
| — | Global Blood Therapeutics, Inc. | 3,217,441 | $131,111 | 0.6% | $44.81 | — | COM | 37890U108 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 12,710,818 | $129,269 | 0.6% | $6.35 | +62.3% | COM | 09058V103 |
| IMCR | Immunocore Holdings plc | 2,520,730 | $107,307 | 0.5% | $42.57 | — | ADS | 45258D105 |
| PACB | Pacific Biosciences of California, Inc. | 3,201,972 | $106,658 | 0.5% | $5.76 | +508.0% | COM | 69404D108 |
| — | Instil Bio, Inc. | 3,893,700 | $97,654 | 0.4% | $25.08 | — | COM | 45783C101 |
| — | Talis Biomedical Corporation | 7,574,835 | $97,337 | 0.4% | $12.85 | — | COM | 87424L108 |
| HRTX | Heron Therapeutics, Inc. | 5,994,704 | $97,174 | 0.4% | $17.78 | +0.3% | COM | 427746102 |
| CERS | Cerus Corporation | 13,713,195 | $82,416 | 0.4% | $4.64 | +46.6% | COM | 157085101 |
| — | Allakos Inc. | 703,050 | $80,696 | 0.3% | $62.02 | — | COM | 01671P100 |
| — | DBV Technologies S.A. | 14,614,264 | $77,894 | 0.3% | $19.06 | — | SPONSORED ADR | 23306J101 |
| NRIX | Nurix Therapeutics, Inc. | 2,454,082 | $76,297 | 0.3% | $28.63 | +32.2% | COM | 67080M103 |
| KYMR | Kymera Therapeutics, Inc. | 1,959,211 | $76,135 | 0.3% | $30.53 | +97.2% | COM | 501575104 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 3,479,873 | $74,017 | 0.3% | $27.43 | +5.8% | COM | 76243J105 |
| INSM | Insmed Incorporated | 2,156,001 | $73,433 | 0.3% | $22.18 | +72.3% | COM PAR $.01 | 457669307 |
| APLS | Apellis Pharmaceuticals, Inc. | 1,674,004 | $71,832 | 0.3% | $37.28 | +26.9% | COM | 03753U106 |
| NBIX | Neurocrine Biosciences, Inc. | 676,975 | $65,836 | 0.3% | $62.87 | +66.8% | COM | 64125C109 |
| KRYS | Krystal Biotech, Inc. | 760,412 | $58,582 | 0.3% | $26.63 | +173.0% | COM | 501147102 |
| — | Forma Therapeutics Holdings, Inc. | 2,024,876 | $56,737 | 0.2% | $45.04 | — | SHS | 34633R104 |
| — | Horizon Therapeutics Public Ltd Co | 599,110 | $55,142 | 0.2% | $63.26 | — | SHS | G46188101 |
| — | Atreca, Inc. | 3,532,760 | $54,157 | 0.2% | $18.84 | — | CL A COM | 04965G109 |
| — | Zymeworks Inc. | 1,708,472 | $53,954 | 0.2% | $14.76 | — | COM | 98985W102 |
| ADAPY | Adaptimmune Therapeutics plc | 9,830,877 | $52,202 | 0.2% | $5.77 | — | SPONSORED ADR | 00653A107 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $51,820 | 0.2% | $17.35 | — | COM CL A | G5269C101 |
| RARE | Ultragenyx Pharmaceutical Inc. | 444,444 | $50,604 | 0.2% | $118.63 | +14.8% | COM | 90400D108 |
| — | Neoleukin Therapeutics, Inc. | 3,821,740 | $47,046 | 0.2% | $3.87 | — | COM | 64049K104 |
| IMTX | Immatics N.V. | 3,992,756 | $44,759 | 0.2% | $10.98 | +3.3% | SHS | N44445109 |
| DSGN | Design Therapeutics, Inc. | 1,436,636 | $42,955 | 0.2% | $31.14 | 0.0% | COM | 25056L103 |
| — | Achilles Therapeutics plc | 2,591,366 | $42,887 | 0.2% | $16.55 | — | SPONSORED ADS | 00449L102 |
| — | Merus N.V. | 2,037,469 | $42,563 | 0.2% | $10.77 | — | COM | N5749R100 |
| — | Verastem, Inc. | 17,019,294 | $42,038 | 0.2% | $2.27 | — | COM | 92337C104 |
| BCAB | BioAtla, Inc. | 825,000 | $41,943 | 0.2% | $33.43 | +53.3% | COM | 09077B104 |
| ALT | Altimmune, Inc. | 2,758,518 | $38,978 | 0.2% | $9.32 | +73.4% | COM | 02155H200 |
| FLGT | Fulgent Genetics, Inc. | 401,016 | $38,746 | 0.2% | $11.30 | +813.9% | COM | 359664109 |
| PTGX | Protagonist Therapeutics, Inc. | 1,436,192 | $37,197 | 0.2% | $9.97 | +153.8% | COM | 74366E102 |
| — | Aligos Therapeutics, Inc. | 1,610,000 | $36,611 | 0.2% | $27.65 | — | COM | 01626L105 |
| AXSM | Axsome Therapeutics, Inc. | 628,414 | $35,581 | 0.2% | $23.39 | +200.8% | COM | 05464T104 |
| ADCT | ADC Therapeutics SA | 1,418,107 | $34,616 | 0.2% | $38.22 | -24.2% | SHS | H0036K147 |
| — | ChemoCentryx, Inc. | 656,710 | $33,650 | 0.1% | $35.60 | — | COM | 16383L106 |
| OPTEY | Opthea Limited | 3,308,705 | $31,664 | 0.1% | $11.21 | — | SPONSORED ADS | 68386J208 |
| — | Aeglea BioTherapeutics, Inc. | 3,410,106 | $27,008 | 0.1% | $7.84 | — | COM | 00773J103 |
| NVAX | Novavax, Inc. | 143,756 | $26,064 | 0.1% | $38.25 | +421.0% | COM | 670002401 |
| ALKS | Alkermes plc | 1,228,170 | $22,942 | 0.1% | $23.07 | -11.3% | SHS | G01767105 |
| MREO | Mereo BioPharma Group plc | 6,719,948 | $22,646 | 0.1% | $3.56 | — | ADS | 589492107 |
| — | Reata Pharmaceuticals, Inc. | 223,976 | $22,330 | 0.1% | $138.99 | — | CL A | 75615P103 |
| — | Otonomy, Inc. | 7,220,074 | $18,411 | 0.1% | $2.55 | — | COM | 68906L105 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,410,064 | $18,310 | 0.1% | $9.21 | +57.5% | COM | 05156V102 |
| EWTX | Edgewise Therapeutics, Inc. | 500,000 | $16,250 | 0.1% | $32.43 | 0.0% | COM | 28036F105 |
| XNCR | Xencor, Inc. | 369,370 | $15,905 | 0.1% | $11.07 | +328.2% | COM | 98401F105 |
| — | Invitae Corporation | 10,300,000 | $15,557 | 0.1% | $1.64 | — | NOTE 2.0% 9/1/2024 | 46185LAB9 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15,299 | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | Athira Pharma, Inc. | 806,367 | $14,837 | 0.1% | $18.46 | — | COM | 04746L104 |
| — | Albireo Pharma, Inc. | 412,466 | $14,539 | 0.1% | $24.96 | — | COM | 01345P106 |
| XENE | Xenon Pharmaceuticals Inc. | 751,639 | $13,454 | 0.1% | $13.09 | +29.5% | COM | 98420N105 |
| MIRM | Mirum Pharmaceuticals, Inc. | 647,313 | $12,830 | 0.1% | $14.86 | +28.8% | COM | 604749101 |
| — | Sarepta Therapeutics, Inc. | 9,174,000 | $11,970 | 0.1% | $1.30 | — | DBCV 1.5% 11/15/2024 | 803607AB6 |
| — | Chinook Therapeutics, Inc. | 748,693 | $11,635 | 0.1% | $15.86 | — | COM | 16961L106 |
| SPRY | Silverback Therapeutics, Inc. | 238,095 | $10,388 | 0.0% | $33.40 | +41.7% | COM | 82835W108 |
| RVMD | Revolution Medicines, Inc. | 222,222 | $10,196 | 0.0% | $44.84 | 0.0% | COM | 76155X100 |
| — | Cymabay Therapeutics, Inc. | 2,170,464 | $9,854 | 0.0% | $5.48 | — | COM | 23257D103 |
| — | Genetron Holdings Limited | 455,306 | $9,771 | 0.0% | $13.55 | — | ADS | 37186H100 |
| — | HOOKIPA Pharma Inc. | 700,481 | $9,421 | 0.0% | $6.73 | — | COM | 43906K100 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 616,520 | $9,420 | 0.0% | $18.19 | -14.8% | COM | 22663K107 |
| ANAB | AnaptysBio, Inc. | 427,179 | $9,206 | 0.0% | $26.06 | -3.1% | COM | 032724106 |
| — | IVERIC bio, Inc. | 1,406,037 | $8,689 | 0.0% | $3.89 | — | COM | 46583P102 |
| — | NGM Biopharmaceuticals, Inc. | 291,801 | $8,483 | 0.0% | $23.80 | — | COM | 62921N105 |
| — | Karuna Therapeutics, Inc. | 69,966 | $8,412 | 0.0% | $91.25 | — | COM | 48576A100 |
| — | Gamida Cell Ltd. | 1,037,226 | $8,391 | 0.0% | $6.83 | — | SHS | M47364100 |
| — | Assembly Biosciences, Inc. | 1,541,418 | $7,091 | 0.0% | $17.50 | — | COM | 045396108 |
| CABA | Cabaletta Bio, Inc. | 636,363 | $7,064 | 0.0% | $11.85 | +3.1% | COM | 12674W109 |
| — | bluebird bio, Inc. | 226,988 | $6,844 | 0.0% | $58.05 | — | COM | 09609G100 |
| MGNX | MacroGenics, Inc. | 200,679 | $6,392 | 0.0% | $23.02 | +5.5% | COM | 556099109 |
| — | Burning Rock Biotech Limited | 209,131 | $5,630 | 0.0% | $27.01 | — | SPONSORED ADS | 12233L107 |
| — | NexImmune, Inc. | 294,117 | $5,612 | 0.0% | $19.08 | — | COM | 65344D109 |
| SGMO | Sangamo Therapeutics, Inc. | 429,063 | $5,376 | 0.0% | $11.28 | +19.4% | COM | 800677106 |
| — | Orchard Therapeutics plc | 734,431 | $5,332 | 0.0% | $10.55 | — | ADS | 68570P101 |
| — | Syros Pharmaceuticals, Inc. | 690,167 | $5,162 | 0.0% | $13.72 | — | COM | 87184Q107 |
| — | Iteos Therapeutics, Inc. | 150,346 | $5,139 | 0.0% | $24.67 | — | COM | 46565G104 |
| DNLI | Denali Therapeutics Inc. | 88,738 | $5,067 | 0.0% | $20.86 | +220.9% | COM | 24823R105 |
| ALEC | Alector, Inc. | 239,228 | $4,818 | 0.0% | $25.49 | -29.7% | COM | 014442107 |
| — | Evofem Biosciences, Inc. | 2,697,110 | $4,720 | 0.0% | $2.13 | — | COM | 30048L104 |
| REPL | Replimune Group, Inc. | 153,512 | $4,684 | 0.0% | $22.66 | +65.3% | COM | 76029N106 |
| TVTX | Travere Therapeutics, Inc. | 186,915 | $4,667 | 0.0% | $27.63 | 0.0% | COM | 89422G107 |
| SRPT | Sarepta Therapeutics, Inc. | 58,700 | $4,375 | 0.0% | $92.28 | 0.0% | COM | 803607100 |
| — | Passage Bio, Inc. | 235,362 | $4,114 | 0.0% | $15.75 | — | COM | 702712100 |
| HRMY | Harmony Biosciences Holdings, Inc. | 123,600 | $4,084 | 0.0% | $36.46 | -3.8% | COM | 413197104 |
| — | TCR2 Therapeutics Inc. | 176,461 | $3,896 | 0.0% | $20.97 | — | COM | 87808K106 |
| — | Tricida, Inc. | 729,300 | $3,858 | 0.0% | $6.81 | — | COM | 89610F101 |
| — | Akero Therapeutics, Inc. | 118,378 | $3,434 | 0.0% | $30.79 | — | COM | 00973Y108 |
| LEGN | Legend Biotech Corporation | 115,626 | $3,355 | 0.0% | $42.56 | — | SPONSORED ADS | 52490G102 |
| — | LogicBio Therapeutics, Inc. | 451,478 | $3,287 | 0.0% | $7.63 | — | COM | 54142F102 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $3,143 | 0.0% | $30.96 | -40.1% | COM STK | 74365U107 |
| — | Acceleron Pharma Inc. | 22,430 | $3,042 | 0.0% | $89.85 | — | COM | 00434H108 |
| — | Constellation Pharmaceuticals, Inc. | 114,735 | $2,684 | 0.0% | $6.73 | — | COM | 210373106 |
| — | Idera Pharmaceuticals, Inc. | 2,047,180 | $2,661 | 0.0% | $1.32 | — | COM PAR | 45168K405 |
| AUTL | Autolus Therapeutics plc | 461,726 | $2,646 | 0.0% | $15.17 | — | SPONSORED ADS | 05280R100 |
| — | Chiasma, Inc. | 742,133 | $2,323 | 0.0% | $5.38 | — | COM | 16706W102 |
| VKTX | Viking Therapeutics, Inc. | 363,980 | $2,302 | 0.0% | $11.90 | -40.9% | COM | 92686J106 |
| — | Inozyme Pharma, Inc. | 106,999 | $2,119 | 0.0% | $26.29 | — | COM | 45790W108 |
| — | Molecular Templates, Inc. | 133,833 | $1,689 | 0.0% | $7.45 | — | COM | 608550109 |
| — | Affimed N.V. | 164,605 | $1,302 | 0.0% | $6.30 | — | COM | N01045108 |
| — | Oyster Point Pharma, Inc. | 61,424 | $1,123 | 0.0% | $28.88 | — | COM | 69242L106 |
| — | Leap Therapeutics, Inc. | 559,705 | $1,063 | 0.0% | $1.17 | — | COM | 52187K101 |
| — | Bellicum Pharmaceuticals, Inc. | 249,123 | $937 | 0.0% | $4.71 | — | COM | 079481404 |
| GLPG | Galapagos NV | 11,180 | $862 | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | Kezar Life Sciences, Inc. | 139,676 | $832 | 0.0% | $5.18 | — | COM | 49372L100 |
| — | Adamas Pharmaceuticals, Inc. | 147,996 | $710 | 0.0% | $14.46 | — | COM | 00548A106 |
| — | Galmed Pharmaceuticals Ltd. | 184,927 | $634 | 0.0% | $11.90 | — | SHS | M47238106 |
| IFRX | Inflarx N.V. | 138,040 | $538 | 0.0% | $2.91 | +76.1% | COM | N44821101 |
| — | Frequency Therapeutics, Inc. | 55,555 | $528 | 0.0% | $17.53 | — | COM | 35803L108 |
| GNFTY | Genfit SA | 14,720 | $68 | 0.0% | $14.24 | — | ADS | 372279109 |